As the cost to bring therapeutic candidates to market rises, scientists search for ways to streamline clinical trials. To reduce patient response variability and increase trial efficacy, it is important to develop screening methods that select the patients most likely to respond to a treatment. Thorough genetic analysis of patients prior to trial enrollment can reveal genetic indicators of therapeutic success to help researchers properly stratify patient cohorts and maximize trial efficiency.
Download this white paper from Thermo Fisher Scientific to learn about
- How genetic technologies, such as qPCR and digital PCR, can be used to stratify patients for clinical trials
- The benefits of genetic analysis on clinical trial design and efficacy
- The rising interest of pharmaceutical and biotech companies in clinical trials that involve genetic analysis